ESTRO35 Programme Book

SATURDAY 30 APRIL 2016

Teaching Lecture CHALLENGES INMR GUIDED RADIOTHERAPY 08:00 - 08:40 | ROOM 1 Chair: C. Kirisits (Austria) 08:00 > Challenges in MR guided radiotherapy Speaker: J. Jonsson (Sweden)

SP-0006

Teaching Lecture PATIENT SPECIFIC QUALITY ASSURANCE IN PROTON THERAPY 08:00 - 08:40 | ROOM 500 Chair: S. Molinelli (Italy) 08:00 > Patient specific quality assurance in proton therapy Speaker: R. Amos (UK) Teaching Lecture BALANCING TOXICITY AND DISEASE CONTROL IN THE EVOLUTION OF RADIOTHERAPY TECHNOLOGY 08:00 - 08:40 | ROOM 3 Chair: A. Vaandering (Belgium) 08:00 > Balancing toxicity and disease control in the evolution of radiotherapy technology Speaker: B. O’Sullivan (Canada)

SP-0007

SP-0008

Symposium SELECTION OF PATIENTS FOR PROTON THERAPY 08:45 - 10:00 | ROOM 2

This session will provide three different views on how to select the patients for proton therapy. Proton therapy is not magic and proton therapy risk within the target volume is identical to other radiation therapies, the differences are most often in the intermediate and low dose volumes outside the target. Comparative treatment planning is essential and it should be free from observer bias. Automated treatment planning and robust optimisation techniques should be considered. NTCP modeling is sug- gested as an unbiased method for patient selection. Differences in DVHs (Δdose) require translation into clinical effects (ΔNTCP) to become clinically meaningful..

Chair: M. Hoyer (Denmark) Co-Chair: M. Ciocca (Italy)

08:45 > Patient selection for proton therapy: a clinicians view Speaker: A. Mahajan (USA)

SP-0009

09:10 > Selection of patients for proton therapy: a physicists view Speaker: M. Hoogeman (The Netherlands)

SP-0010

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

59